1-12 of 12
Louis Staudt, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS

Mark Roschewski, MD, Christopher Melani, MD, Kieron Dunleavy, MD, Matthias Holdhoff, MD PhD, Lode J. Swinnen, MB ChB, Michael Glantz, MD PhD, Craig A. Portell, MD, Jakub Svoboda, MD, Rafic Farah, MD, Michail S. Lionakis, MD ScD, Louis Staudt, MD, Wyndham Wilson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2875.
https://doi.org/10.1182/blood-2019-123552
Published: 2019
Journal Articles

PRISM: A Platform Protocol for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Mark Roschewski, MD, Raquel Izumi, PhD, Ahmed Hamdy, MD, Manish R. Patel, MD, Hendrik-Tobias Arkenau, MD PhD, Sven de Vos, MD PhD, Patrick M Reagan, MD, Pier Luigi Zinzani, MD PhD, Andrew Davies, MD PhD, John M Pagel, MD PhD, Julie M Vose, MDMBA, Bojena Bitman, Graham Brock, PhD, Edwin Clark, PhD, Melanie M. Frigault, PhD, Joseph Ware, PhD, Buyue Yang, MD PhD, Wyndham Wilson, MD, Louis Staudt, MD, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2869.
https://doi.org/10.1182/blood-2019-125939
Published: 2019
Journal Articles

Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis

Christopher Melani, MD, Rahul Lakhotia, MD, Stefania Pittaluga, MD PhD, Milos D. Miljkovic, MDMSc, Jagan R. Muppidi, MD PhD, Craig A. Portell, MD, Rafic Farah, MD, Seung Tae Lee, MD PhD, Anna Marie Juanitez, RN, Lydia L. Chou, CRNP, Seth M. Steinberg, PhD, Elaine S. Jaffe, MD, Louis Staudt, MD, Mark Roschewski, MD, Wyndham Wilson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2867.
https://doi.org/10.1182/blood-2019-125990
Published: 2019
Journal Articles

Genome-Wide CRISPR Library Screening Identifies CDK6 As Genetic Vulnerability in Adult T-Cell Leukemia/Lymphoma

Takashi Ishio, Joji Shimono, Sarvesh Kumar, Yuquan Lin, Emmanuel Bachy, Michael N. Petrus, Yandan Yang, Michiyuki Maeda, Hideki Goto, Satoshi Hashino, Takanori Teshima, MD, Thomas A. Waldmann, MD, Louis Staudt, MD, Masao Nakagawa
Journal: Blood
Blood (2019) 134 (Supplement_1): 3781.
https://doi.org/10.1182/blood-2019-124670
Published: 2019
Journal Articles

KLHL14 Is a Tumor Suppressor in Diffuse Large B-Cell Lymphoma

Jaewoo Choi, PhD, James D Phelan, PhD, Ryan M. Young, PhD, Thomas Oellerich, MD, Da Wei Huang, MD, Arthur L Shaffer, PhD, Louis Staudt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2766.
https://doi.org/10.1182/blood-2019-125137
Published: 2019
Journal Articles

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Tayla B Heavican, BS, Jiayu Yu, MD MS, Alyssa Bouska, PhD, Timothy C Greiner, MS, MD, Cynthia M Lachel, BS, Chao Wang, MD, Bhavana J Dave, Catalina C Amador, MD, Kai Fu, MD PhD, Julie M Vose, MD, Dennis D Weisenburger, MD, Randy D Gascoyne, MD, Sylvia Hartmann, MD, Martin Bjerregård Pedersen, Ryan Wilcox, MD PhD, Bin Tean Teh, MD PhD, Soon Thye Lim, MD, Choon Kiat Ong, Masao Seto, MD PhD, Francoise Berger, Andreas Rosenwald, MD, German Ott, Elias Campo, Lisa M Rimsza, MD, Elaine S. Jaffe, MD, Rita M Braziel, MD, Francesco A d'Amore, MD, Giorgio Inghirami, MD, Francesco Bertoni, MD, Louis Staudt, MD PhD, Timothy W. McKeithan, MD PhD, Stefano A Pileri, Wing Chung Chan, MD, Javeed Iqbal, PhD
Journal: Blood
Blood (2016) 128 (22): 4096.
https://doi.org/10.1182/blood.V128.22.4096.4096
Published: 2016
Journal Articles

Integrating Genomic Alterations in Diffuse Large B-Cell Lymphoma Identifies New Relevant Pathways and Potential Therapeutic Targets

Ivan Dlouhy, MD, Kennosuke Karube, MDPhD, Anna Enjuanes, David Martín-García, Ferran Nadeu, Gonzalo R Ordoñez, Jordina Rovira, Cristina Royo, Alba Navarro, Blanca Gonzalez, Giancarlo Castellano, Carlota Rubio-Perez, David Tamborero, PhD, Javier Briones, PhD MD, Antonio Salar, MD PhD, Juan-Manuel Sancho, Santiago Mercadal, Eva Gonzalez Barca, PhD, Lourdes Escoda, MD PhD, Miyoshi Hiroaki, MD PhD, Koichi Ohshima, MD PhD, Koji Kato, MD PhD, Koichi Akashi, MD PhD, Anna Mozos, Lluis Colomo, MD PhD, Miguel Alcoceba, BSc, PhD, Alexandra Valera, Anna Carrio, Nuria Lopez-Bigas, Roland Schmitz, PhD, Louis Staudt, MD PhD, Pedro Jares, Itziar Salaverria, Armando López-Guillermo, Elias Campo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 152.
https://doi.org/10.1182/blood.V128.22.152.152
Published: 2016
Journal Articles

Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients.

Kieron Dunleavy, MD, Stefania Pittaluga, MD, John Janik, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Seth Steinberg, PhD, Mark Raffeld, MD, Louis Staudt, MD, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 209.
https://doi.org/10.1182/blood.V108.11.209.209
Published: 2006
Journal Articles

DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers.

Wyndham H. Wilson, MD, PhD, Kieron Dunleavy, MD, Stefania Pittaluga, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Seth Steinberg, PhD, Mark Raffeld, MD, Louis Staudt, MD, PhD, Elaine S. Jaffe, MD, John Janik, MD
Journal: Blood
Blood (2006) 108 (11): 206.
https://doi.org/10.1182/blood.V108.11.206.206
Published: 2006
Journal Articles

Biological Differences in Peripheral T-Cell Lymphomas Identified by DNA Microarrays.

Beatriz Martinez-Delgado, PhD, Manisha Bahl, Marta Cuadros, Victoria Fernandez, Javier Benitez, PhD, Elaine S. Jaffe, MD, PhD, Louis Staudt, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3012.
https://doi.org/10.1182/blood.V106.11.3012.3012
Published: 2005
Journal Articles

Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome Is Significantly Improved by the Addition of Rituximab to Dose Adjusted (DA)-EPOCH and Overcomes the Need for Radiation.

Kieron Dunleavy, MD, Stefania Pittaluga, MD, John Janik, MD, Nicole Grant, RN, Seth Steinberg, PhD, Louis Staudt, MD, PhD, Elaine Jaffe, MD, Wyndham H. Wilson, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 929.
https://doi.org/10.1182/blood.V106.11.929.929
Published: 2005
Journal Articles

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Andreas Zettl, MD, Silvia Bea, George Wright, PhD, Itziar Salaverria, Philipp Jehn, German Ott, MD, Wing-Chung Chan, MD, Elaine Jaffe, MD, Dennis Weisenburger, MD, Timothy Greiner, MD, James Armitage, MD, Randy Gascoyne, MD, Joseph Connors, MD, Thomas Grogan, MD, Thomas Miller, MD, Richard Fisher, MD, Jan Delabie, MD, Stein Kvaloy, MD, Hans Konrad Mueller-Hermelink, MD, Christof Burek, Victor Moreno, Emilio Montserrat, MD, Wyndham Wilson, MD, Louis Staudt, MD, PhD, Andreas Rosenwald, MD, Elias Campo, for the Leukemia Lymphoma Molecular Profiling Project
Journal: Blood
Blood (2004) 104 (11): 415.
https://doi.org/10.1182/blood.V104.11.415.415
Published: 2004